Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.54
+0.12813.76%
Volume:11.51M
Turnover:40.57M
Market Cap:1.84B
PE:-1.98
High:3.60
Open:3.39
Low:3.38
Close:3.41
52wk High:8.71
52wk Low:2.98
Shares:519.84M
Float Shares:415.00M
Volume Ratio:0.64
T/O Rate:2.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7839
EPS(LYR):-1.6909
ROE:-91.06%
ROA:-42.04%
PB:1.76
PE(LYR):-2.09

Loading ...

Feb 19, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Director Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $138,400
Feb 18, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Taylor Ben R proposes to sell 13426 shares, with a total value of approximately $41352.08.
Feb 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 20, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Director Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $178,800
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 06, 2026

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS' Director B. Borgeson proposes to sell 220,000 shares, with a total value of approximately $959.2K.
Jan 05, 2026

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Director Gibson Christopher proposes to sell 40,000 Shares, with a total value of approximately $170,000.
Dec 29, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Taylor Ben R proposes to sell 21,383 shares, with a total value of approximately $89K.
Dec 22, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Najat Khan proposes to sell 124,403 Shares, with a total value of approximately $548,587.96
Dec 19, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals's Officer Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $180,000.
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 04, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Christopher Gibson proposes to sell 40,000 shares, with a total value of approximately $185,200.
Dec 02, 2025

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS Director Blake Borgeson proposes to sell 220,000 shares, with a total value of approximately $961,400
Nov 26, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS' Director and Officer Gibson proposes to sell 40000 shares, with a total value of approximately $166,400.
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Christopher Gibson proposes to sell 40,000 Shares, with a total value of approximately $208,400.
Oct 29, 2025

Major Issues Report

Form 8-K - Current report